>> Trump to award Medal of Honor to late Air Force sergeant
“Neither of us had any prior experience and any family members with the disease. It was a pretty crash course for us,” Jennifer Loveless said.
John Loveless has been on a different clinical trial where he travels once a month to Columbus. The two have been doing this for almost a year now. With news of a new drug that could potentially treat Alzheimer’s, the two are feeling better about the future.
“It gives me great hope that there is a solution on the way and the drug I’m on shows great promise and hopefully that will be the solution,” John Loveless said.
Since the diagnosis, the couple has been helping with the Alzheimer’s Association Miami Valley Chapter in raising awareness and money for research.
>> The scary reason your cheap sunglasses are bad for your eyes
“It’s more than just a lifeline, it is a connection with other people who are struggling with this devastating disease,” Jennifer Loveless said.
Eric VanVlymen, regional director of the Alzheimer’s Association, said he was at the research conference in Chicago when the announcement about the drug study was made.
“This is a really exciting development,” he said, with the study showing improvement in cognition and functions in patients who were given high doses of the experimental drug. “We’ve not had a lot of great news out of trials in the past five years but now there’s kind of hope.”
>> 9 healthy, delicious school lunch ideas your kids will love
For the first time in years, many living with this disease are hopeful someone will be the first to overcome Alzheimer’s.
“I’m confident today with the research that’s going on we will find a cure,” John Loveless said.
For more information, contact the Alzheimer's Association's 24-hour helpline 800-272-3900.
Got a tip? Call our monitored 24-hour line, 937-259-2237, or send it to email@example.com.